CN114740123A - 一种检测氟雷拉纳含量的方法 - Google Patents
一种检测氟雷拉纳含量的方法 Download PDFInfo
- Publication number
- CN114740123A CN114740123A CN202210468629.3A CN202210468629A CN114740123A CN 114740123 A CN114740123 A CN 114740123A CN 202210468629 A CN202210468629 A CN 202210468629A CN 114740123 A CN114740123 A CN 114740123A
- Authority
- CN
- China
- Prior art keywords
- solution
- performance liquid
- high performance
- reversed
- chromatogram
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Pending
Links
- 238000000034 method Methods 0.000 title claims abstract description 44
- 239000000243 solution Substances 0.000 claims abstract description 29
- 239000012085 test solution Substances 0.000 claims abstract description 29
- 239000007788 liquid Substances 0.000 claims abstract description 21
- 239000012086 standard solution Substances 0.000 claims abstract description 16
- 238000010812 external standard method Methods 0.000 claims abstract description 6
- WEVYAHXRMPXWCK-UHFFFAOYSA-N Acetonitrile Chemical group CC#N WEVYAHXRMPXWCK-UHFFFAOYSA-N 0.000 claims description 111
- 239000002904 solvent Substances 0.000 claims description 18
- 238000004007 reversed phase HPLC Methods 0.000 claims description 16
- 239000000523 sample Substances 0.000 claims description 14
- 238000012360 testing method Methods 0.000 claims description 13
- 238000010828 elution Methods 0.000 claims description 11
- 239000003643 water by type Substances 0.000 claims description 11
- 239000000126 substance Substances 0.000 claims description 9
- 239000007864 aqueous solution Substances 0.000 claims description 8
- 238000002347 injection Methods 0.000 claims description 8
- 239000007924 injection Substances 0.000 claims description 8
- 238000000926 separation method Methods 0.000 claims description 8
- 239000012488 sample solution Substances 0.000 claims description 7
- 238000004128 high performance liquid chromatography Methods 0.000 claims description 6
- 238000000825 ultraviolet detection Methods 0.000 claims description 3
- YWBVHLJPRPCRSD-UHFFFAOYSA-N Fluridone Chemical compound O=C1C(C=2C=C(C=CC=2)C(F)(F)F)=CN(C)C=C1C1=CC=CC=C1 YWBVHLJPRPCRSD-UHFFFAOYSA-N 0.000 claims description 2
- PBCJIPOGFJYBJE-UHFFFAOYSA-N acetonitrile;hydrate Chemical compound O.CC#N PBCJIPOGFJYBJE-UHFFFAOYSA-N 0.000 claims description 2
- 238000002360 preparation method Methods 0.000 abstract description 26
- 102000003869 Frataxin Human genes 0.000 abstract description 6
- 108090000217 Frataxin Proteins 0.000 abstract description 6
- 238000011084 recovery Methods 0.000 abstract description 3
- 230000002441 reversible effect Effects 0.000 abstract description 3
- 238000005220 pharmaceutical analysis Methods 0.000 abstract description 2
- 238000001514 detection method Methods 0.000 description 17
- 239000000463 material Substances 0.000 description 17
- 238000005303 weighing Methods 0.000 description 17
- QNFBKOHHLAWWTC-UHFFFAOYSA-N Fraxidin Chemical compound C1=CC(=O)OC2=C1C=C(OC)C(OC)=C2O QNFBKOHHLAWWTC-UHFFFAOYSA-N 0.000 description 12
- 239000002671 adjuvant Substances 0.000 description 12
- 238000007865 diluting Methods 0.000 description 11
- XLYOFNOQVPJJNP-UHFFFAOYSA-N water Substances O XLYOFNOQVPJJNP-UHFFFAOYSA-N 0.000 description 11
- 238000005259 measurement Methods 0.000 description 10
- 239000012535 impurity Substances 0.000 description 7
- 238000003556 assay Methods 0.000 description 6
- BTCSSZJGUNDROE-UHFFFAOYSA-N gamma-aminobutyric acid Chemical compound NCCCC(O)=O BTCSSZJGUNDROE-UHFFFAOYSA-N 0.000 description 4
- OGNSCSPNOLGXSM-UHFFFAOYSA-N (+/-)-DABA Natural products NCCC(N)C(O)=O OGNSCSPNOLGXSM-UHFFFAOYSA-N 0.000 description 2
- 239000007910 chewable tablet Substances 0.000 description 2
- 229940068682 chewable tablet Drugs 0.000 description 2
- 230000001276 controlling effect Effects 0.000 description 2
- 229960003692 gamma aminobutyric acid Drugs 0.000 description 2
- 229940100613 topical solution Drugs 0.000 description 2
- 241000238876 Acari Species 0.000 description 1
- 206010001497 Agitation Diseases 0.000 description 1
- 241000238682 Amblyomma americanum Species 0.000 description 1
- 241000282472 Canis lupus familiaris Species 0.000 description 1
- 108010062745 Chloride Channels Proteins 0.000 description 1
- 102000011045 Chloride Channels Human genes 0.000 description 1
- 241001480793 Dermacentor variabilis Species 0.000 description 1
- 241000282326 Felis catus Species 0.000 description 1
- 208000006004 Flea Infestations Diseases 0.000 description 1
- 241001481696 Rhipicephalus sanguineus Species 0.000 description 1
- 230000009286 beneficial effect Effects 0.000 description 1
- 230000000052 comparative effect Effects 0.000 description 1
- 238000011161 development Methods 0.000 description 1
- 230000018109 developmental process Effects 0.000 description 1
- 230000008676 import Effects 0.000 description 1
- 208000015181 infectious disease Diseases 0.000 description 1
- 230000002452 interceptive effect Effects 0.000 description 1
- -1 isoxazoline compound Chemical class 0.000 description 1
- 230000007653 larval development Effects 0.000 description 1
- 230000005923 long-lasting effect Effects 0.000 description 1
- 229960003088 loratadine Drugs 0.000 description 1
- JCCNYMKQOSZNPW-UHFFFAOYSA-N loratadine Chemical compound C1CN(C(=O)OCC)CCC1=C1C2=NC=CC=C2CCC2=CC(Cl)=CC=C21 JCCNYMKQOSZNPW-UHFFFAOYSA-N 0.000 description 1
- 238000004519 manufacturing process Methods 0.000 description 1
- 229940000184 moxidectin topical solution Drugs 0.000 description 1
- 210000000653 nervous system Anatomy 0.000 description 1
- 230000017448 oviposition Effects 0.000 description 1
- 244000045947 parasite Species 0.000 description 1
- 239000000546 pharmaceutical excipient Substances 0.000 description 1
- 230000001105 regulatory effect Effects 0.000 description 1
- 230000033458 reproduction Effects 0.000 description 1
- 239000011550 stock solution Substances 0.000 description 1
- 238000006467 substitution reaction Methods 0.000 description 1
- 238000011003 system suitability test Methods 0.000 description 1
- 239000000273 veterinary drug Substances 0.000 description 1
Images
Classifications
-
- G—PHYSICS
- G01—MEASURING; TESTING
- G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
- G01N30/00—Investigating or analysing materials by separation into components using adsorption, absorption or similar phenomena or using ion-exchange, e.g. chromatography or field flow fractionation
- G01N30/02—Column chromatography
-
- G—PHYSICS
- G01—MEASURING; TESTING
- G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
- G01N30/00—Investigating or analysing materials by separation into components using adsorption, absorption or similar phenomena or using ion-exchange, e.g. chromatography or field flow fractionation
- G01N30/02—Column chromatography
- G01N30/04—Preparation or injection of sample to be analysed
- G01N30/06—Preparation
-
- G—PHYSICS
- G01—MEASURING; TESTING
- G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
- G01N30/00—Investigating or analysing materials by separation into components using adsorption, absorption or similar phenomena or using ion-exchange, e.g. chromatography or field flow fractionation
- G01N30/02—Column chromatography
- G01N30/86—Signal analysis
- G01N30/8675—Evaluation, i.e. decoding of the signal into analytical information
-
- G—PHYSICS
- G01—MEASURING; TESTING
- G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
- G01N30/00—Investigating or analysing materials by separation into components using adsorption, absorption or similar phenomena or using ion-exchange, e.g. chromatography or field flow fractionation
- G01N30/02—Column chromatography
- G01N30/04—Preparation or injection of sample to be analysed
- G01N2030/042—Standards
- G01N2030/047—Standards external
Landscapes
- Physics & Mathematics (AREA)
- Health & Medical Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- Chemical & Material Sciences (AREA)
- Analytical Chemistry (AREA)
- Biochemistry (AREA)
- General Health & Medical Sciences (AREA)
- General Physics & Mathematics (AREA)
- Immunology (AREA)
- Pathology (AREA)
- Engineering & Computer Science (AREA)
- Library & Information Science (AREA)
- Investigating Or Analysing Biological Materials (AREA)
Abstract
Description
浓度(mg/ml) | 峰面积 |
0.25 | 4105094 |
0.4 | 6582435 |
0.5 | 8275012 |
0.6 | 9816584 |
0.75 | 12405846 |
Claims (10)
Priority Applications (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
CN202210468629.3A CN114740123A (zh) | 2022-04-29 | 2022-04-29 | 一种检测氟雷拉纳含量的方法 |
Applications Claiming Priority (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
CN202210468629.3A CN114740123A (zh) | 2022-04-29 | 2022-04-29 | 一种检测氟雷拉纳含量的方法 |
Publications (1)
Publication Number | Publication Date |
---|---|
CN114740123A true CN114740123A (zh) | 2022-07-12 |
Family
ID=82286304
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
CN202210468629.3A Pending CN114740123A (zh) | 2022-04-29 | 2022-04-29 | 一种检测氟雷拉纳含量的方法 |
Country Status (1)
Country | Link |
---|---|
CN (1) | CN114740123A (zh) |
Cited By (1)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
CN115266988A (zh) * | 2022-08-01 | 2022-11-01 | 江苏慧聚药业股份有限公司 | 一种氟雷拉钠有关物质的检测方法 |
-
2022
- 2022-04-29 CN CN202210468629.3A patent/CN114740123A/zh active Pending
Cited By (1)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
CN115266988A (zh) * | 2022-08-01 | 2022-11-01 | 江苏慧聚药业股份有限公司 | 一种氟雷拉钠有关物质的检测方法 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
CN109870521B (zh) | 一种正相色谱法分离磷酸奥司他韦对映异构体的方法 | |
CN109060973B (zh) | 一种检测硫辛酸注射液中乙二胺的方法 | |
CN114740123A (zh) | 一种检测氟雷拉纳含量的方法 | |
CN101216468B (zh) | 2-甲氧甲基-4-氨基苯酚及其杂质的高效液相色谱分析方法 | |
WO2013024398A2 (en) | An improved method for the quantitative determination of linezolid | |
CN113702514A (zh) | 一种阿托伐他汀钙有关杂质ⅰ的测定方法 | |
CN115266988A (zh) | 一种氟雷拉钠有关物质的检测方法 | |
CN114324642B (zh) | 一种氢溴酸右美沙芬有关物质的测定方法 | |
CN103185750A (zh) | 一种氯吡格雷拆分试剂的质量控制方法 | |
CN109001342B (zh) | 一种检测n-2,3-二甲氧苄基胡椒乙胺及其盐含量的高效液相方法 | |
CN111307994B (zh) | 一种异噁唑啉类化合物的高效液相色谱分析方法 | |
CN109765316B (zh) | 一种从药物中检测右乙拉西坦的方法 | |
CN110441437A (zh) | 一种米氏酸含量的测定方法 | |
CN112611819B (zh) | 一种苯磷硫胺原料及其制剂中有关物质的测定方法 | |
CN113820409B (zh) | 一种莫西沙星母核中有关物质的检测方法 | |
CN110988175B (zh) | 一种测定西咪替丁中基因毒性杂质丙酮醛的方法 | |
CN114113390B (zh) | 一种氟雷拉纳中间体及其杂质的检测方法 | |
CN113433249B (zh) | 一种高效液相色谱法检测米诺环素中间体有关物质的方法 | |
CN114113388B (zh) | 一种4-肟甲基-1-萘甲酸中有关物质的检测方法 | |
CN113866322B (zh) | 一种反相高效液相色谱检测阿福拉纳中间体的方法 | |
CN113552257B (zh) | 一种hplc法测定对氟苯硫酚中异构体杂质的方法 | |
CN110850012B (zh) | 一种1-(2,3-二氯苯基)哌嗪盐酸盐及其有关物质的检测方法 | |
CN115840008A (zh) | 一种盐酸乌拉地尔原料药中基因毒性杂质的测定方法 | |
CN117571863A (zh) | 一种含有丙二醇的奥硝唑注射液的有关物质检测方法 | |
CN115932149A (zh) | 一种复方避蚊胺含量的检测方法 |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
PB01 | Publication | ||
PB01 | Publication | ||
SE01 | Entry into force of request for substantive examination | ||
SE01 | Entry into force of request for substantive examination | ||
TA01 | Transfer of patent application right |
Effective date of registration: 20240424 Address after: No. 8 Shilong Avenue, Xinji Village Committee, Shijiao Town, Qingcheng District, Qingyuan City, Guangdong Province 511545. Lizhu Group Xinbeijiang Pharmaceutical Co., Ltd. has built Workshop 201 (third floor) and Workshop 202 (fourth floor) for animal protection Applicant after: Lijian (Guangdong) Animal Health Co.,Ltd. Country or region after: China Address before: 511518 Renmin 1st Road, Qingyuan City, Guangdong Province Applicant before: LIVZON NEW NORTH RIVER PHARMACEUTICAL Co.,Ltd. Country or region before: China |
|
TA01 | Transfer of patent application right |